Clinical trial
Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer
NCT00398281 · Sidney Kimmel Cancer Center at Thomas Jefferson University, Other · Completed
Key facts
| NCT number | NCT00398281 |
|---|---|
| Title | Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer |
| Official title | Detection of Prostate Cancer With Contrast-Enhanced Ultrasound After Treatment With Dutasteride |
| Lead sponsor | Sidney Kimmel Cancer Center at Thomas Jefferson University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Other |
| Interventions | dutasteride, placebo |
| Enrollment | 450 |
| Start date | Nov 1, 2006 |
| Primary completion | Jul 1, 2010 |
| Completion | Sep 1, 2012 |
| First posted | Nov 10, 2006 |
| Last update posted | Jan 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: